These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15034017)

  • 1. Proinflammatory mediators and genetic background in oncogene mediated tumor progression.
    Russell JP; Engiles JB; Rothstein JL
    J Immunol; 2004 Apr; 172(7):4059-67. PubMed ID: 15034017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A thyroid tumor-specific antigen formed by the fusion of two self proteins.
    Powell DJ; Eisenlohr LC; Rothstein JL
    J Immunol; 2003 Jan; 170(2):861-9. PubMed ID: 12517951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncoprotein signaling mediates tumor-specific inflammation and enhances tumor progression.
    Pufnock JS; Rothstein JL
    J Immunol; 2009 May; 182(9):5498-506. PubMed ID: 19380798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine kinase oncoprotein, RET/PTC3, induces the secretion of myeloid growth and chemotactic factors.
    Russell JP; Shinohara S; Melillo RM; Castellone MD; Santoro M; Rothstein JL
    Oncogene; 2003 Jul; 22(29):4569-77. PubMed ID: 12881713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papilloma virus 16 E7 oncogene does not cooperate with RET/PTC 3 oncogene in the neoplastic transformation of thyroid cells in transgenic mice.
    Portella G; Borselli C; Santoro M; Gerbasio D; D'Armiento MR; Dumont JE; Ledent C; Rothstein JL; Vecchio G; Fusco A
    Oncol Res; 2001; 12(8):347-54. PubMed ID: 11589306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression in RET/PTC3 and E7 transgenic mouse thyroids: RET/PTC3 but not E7 tumors are partial and transient models of human papillary thyroid cancers.
    Burniat A; Jin L; Detours V; Driessens N; Goffard JC; Santoro M; Rothstein J; Dumont JE; Miot F; Corvilain B
    Endocrinology; 2008 Oct; 149(10):5107-17. PubMed ID: 18583418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of siRNA on RET/PTC3 junction oncogene in papillary thyroid carcinoma: from molecular and cellular studies to preclinical investigations.
    Ali HM; Urbinati G; Chapuis H; Desmaele D; Bertrand JR; Couvreur P; Massaad-Massade L
    PLoS One; 2014; 9(4):e95964. PubMed ID: 24759995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.
    Russell JP; Powell DJ; Cunnane M; Greco A; Portella G; Santoro M; Fusco A; Rothstein JL
    Oncogene; 2000 Nov; 19(50):5729-35. PubMed ID: 11126359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
    Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.
    Mechler C; Bounacer A; Suarez H; Saint Frison M; Magois C; Aillet G; Gaulier A
    Br J Cancer; 2001 Dec; 85(12):1831-7. PubMed ID: 11747322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RET/PTC3 oncogene activates classical NF-κB by stabilizing NIK.
    Neely RJ; Brose MS; Gray CM; McCorkell KA; Leibowitz JM; Ma C; Rothstein JL; May MJ
    Oncogene; 2011 Jan; 30(1):87-96. PubMed ID: 20818435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of phosphotyrosines-294, -404, and -451 in RET/PTC1-induced thyroid tumor formation.
    Buckwalter TL; Venkateswaran A; Lavender M; La Perle KM; Cho JY; Robinson ML; Jhiang SM
    Oncogene; 2002 Nov; 21(53):8166-72. PubMed ID: 12444552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
    Kim DW; Hwang JH; Suh JM; Kim H; Song JH; Hwang ES; Hwang IY; Park KC; Chung HK; Kim JM; Park J; Hemmings BA; Shong M
    Mol Endocrinol; 2003 Jul; 17(7):1382-94. PubMed ID: 12738763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases.
    Hwang ES; Kim DW; Hwang JH; Jung HS; Suh JM; Park YJ; Chung HK; Song JH; Park KC; Park SH; Yun HJ; Kim JM; Shong M
    Mol Endocrinol; 2004 Nov; 18(11):2672-84. PubMed ID: 15297606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of connexin32 deletion on E7 or RET/PTC3 oncogene-driven growth and neoplastic transformation of the thyroid gland.
    Prost G; Bernier-Valentin F; Croset M; Rousset B
    Endocr Relat Cancer; 2009 Sep; 16(3):873-84. PubMed ID: 19509066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 24 is induced by the RET/PTC3 oncoprotein and is an autocrine growth factor for epithelial cells.
    Shinohara S; Rothstein JL
    Oncogene; 2004 Sep; 23(45):7571-9. PubMed ID: 15326486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation.
    Hwang JH; Kim DW; Suh JM; Kim H; Song JH; Hwang ES; Park KC; Chung HK; Kim JM; Lee TH; Yu DY; Shong M
    Mol Endocrinol; 2003 Jun; 17(6):1155-66. PubMed ID: 12637586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcript level modulates the inherent oncogenicity of RET/PTC oncoproteins.
    Richardson DS; Gujral TS; Peng S; Asa SL; Mulligan LM
    Cancer Res; 2009 Jun; 69(11):4861-9. PubMed ID: 19487296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice.
    Cho JY; Sagartz JE; Capen CC; Mazzaferri EL; Jhiang SM
    Oncogene; 1999 Jun; 18(24):3659-65. PubMed ID: 10380889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications.
    Joung JY; Kim TH; Jeong DJ; Park SM; Cho YY; Jang HW; Jung YY; Oh YL; Yim HS; Kim YL; Chung JH; Ki CS; Kim SW
    Histopathology; 2016 Jul; 69(1):45-53. PubMed ID: 26568156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.